Friedlander, Robert M.

Prophylactic Creatine Administration Mediates Neuroprotection in Cerebral Ischemia in Mice

Zhu, S., Li, M., Figueroa, B. E., Liu, A., Stavrovskaya, I. G., Pasinelli, P., Beal, M. F., Brown, R. H., Kristal, B. S., Ferrante, R. J., et al. (2004) · The Journal of Neuroscience

Neuroprotection in Cerebral IschemiaAcute Ischemic Stroke Management

Cited by 138

Effects of caspase-1 knockout on chronic neural recording quality and longevity: Insight into cellular and molecular mechanisms of the reactive tissue response

Kozai, T. D. Y., Li, X., Bodily, L. M., Caparosa, E. M., Zenonos, G. A., Carlisle, D. L., Friedlander, R. M., & Cui, X. T. (2014) · Biomaterials

Neuroscience and Neural EngineeringNeuroinflammation and Neurodegeneration Mechanisms

Cited by 136

Combination therapy using minocycline and coenzyme Q10 in R6/2 transgenic Huntington's disease mice

Stack, E. C., Smith, K. M., Ryu, H., Cormier, K., Chen, M., Hagerty, S. W., Del Signore, S. J., Cudkowicz, M. E., Friedlander, R. M., & Ferrante, R. J. (2006) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease

Genetic Neurodegenerative DiseasesCoenzyme Q10 studies and effects

Cited by 114

Nortriptyline Protects Mitochondria and Reduces Cerebral Ischemia/Hypoxia Injury

Zhang, W.-H., Wang, H., Wang, X., Narayanan, M. V., Stavrovskaya, I. G., Kristal, B. S., & Friedlander, R. M. (2008) · Stroke

Neuroprotection in Cerebral IschemiaMitochondrial Function and Pathology

Cited by 80

Moving toward a gene therapy for Huntington’s disease

Glorioso, J. C., Cohen, J. B., Carlisle, D. L., Munoz-Sanjuan, I., & Friedlander, R. M. (2015) · Gene Therapy

Genetic Neurodegenerative DiseasesVirus-based gene therapy research

Cited by 20